Suanne K Nakajima

Address:

19 Nassau Dr, Winchester, MA 01890

VIN:

JTDKN3DU3A1201279

Make:

TOYOTA

Model:

PRIUS

Year:

2010

US Patent:

6951872, Oct 4, 2005

Filed:

Dec 8, 2003

Appl. No.:

10/730170

Inventors:

Irina C. Jacobson - Sammamish WA, US
Ruth R. Wexler - Chadds Ford PA, US
Suanne Nakajima - Cambridge MA, US
Mimi L. Quan - Yardley PA, US
Shuaige Wang - West Chester PA, US
Joanne M. Smallheer - Yardley PA, US
Jennifer Qiao - Princeton NJ, US

Assignee:

Bristol-Myers Squibb Pharma Company - Princeton NJ

International Classification:

C07D211/06
A61K031/445
A61P007/02

US Classification:

514319, 546205

Abstract:

The present application describes monocyclic or bicyclic carbocycles and heterocycles and derivatives thereof of Formula I: or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.

US Patent:

7125845, Oct 24, 2006

Filed:

Jul 3, 2003

Appl. No.:

10/613206

Inventors:

Frank X. H. Wu - Shrewsbury MA, US
Suanne Nakajima - Cambridge MA, US
Zhi-Hui Lu - Shrewsbury MA, US
Ying Sun - Waltham MA, US
Zhenwei Miao - Medway MA, US
Yat Sun Or - Watertown MA, US
Zhe Wang - Hockessin DE, US

Assignee:

Enanta Pharmaceuticals, Inc. - Watertown MA

International Classification:

A61K 38/00

US Classification:

514 10

Abstract:

The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof:.

US Patent:

7176208, Feb 13, 2007

Filed:

Apr 16, 2004

Appl. No.:

10/826743

Inventors:

Suanne Nakajima - Cambridge MA, US
Zhenwei Miao - Medway MA, US
Ying Sun - Waltham MA, US
Datong Tang - Malden MA, US
Guoyou Xu - Auburndale MA, US
Brian Porter - Cambridge MA, US
Yat Sun Or - Watertown MA, US
Zhe Wang - Hockessin DE, US

Assignee:

Enanta Pharmaceuticals, Inc. - Watertown MA

International Classification:

C07D 401/12
C07D 409/14
A61K 31/38
A61K 31/395
A61P 31/12

US Classification:

51425505, 540455, 540460

Abstract:

The present invention relates to compounds of Formula I or II, or a pharmaceutically acceptable salt, ester, or prodrug, thereof:.

US Patent:

7273851, Sep 25, 2007

Filed:

May 19, 2004

Appl. No.:

10/849107

Inventors:

Zhenwei Miao - San Diego CA, US
Ying Sun - Waltham MA, US
Suanne Nakajima - Cambridge MA, US
Datong Tang - Malden MA, US
Zhe Wang - Hockessin DE, US
Yat S. Or - Watertown MA, US

Assignee:

Enanta Pharmaceuticals, Inc. - Watertown MA

International Classification:

A61K 38/00

US Classification:

514 18

Abstract:

The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof:.

US Patent:

7368452, May 6, 2008

Filed:

Jul 18, 2006

Appl. No.:

11/489011

Inventors:

Suanne Nakajima - Cambridge MA, US
Zhenwei Miao - Medway MA, US
Ying Sun - Waltham MA, US
Datong Tang - Malden MA, US
Gouyou Xu - Auburndale MA, US
Brian Porter - Cambridge MA, US
Yat Sun Or - Watertown MA, US
Zhe Wang - Hockessin DE, US

Assignee:

Enanta Pharmaceuticals, Inc. - Watertown MA

International Classification:

A61P 31/12

US Classification:

51425505

Abstract:

The present invention relates to compounds of Formula I or II, or a pharmaceutically acceptable salt, ester, or prodrug, thereof:.

US Patent:

7566719, Jul 28, 2009

Filed:

Mar 6, 2008

Appl. No.:

12/043421

Inventors:

Suanne Nakajima - Winchester MA, US
Zhenwei Miao - San Diego CA, US
Ying Sun - Waltham MA, US
Datong Tang - Newton MA, US
Guoyou Xu - Framingham MA, US
Brian Porter - Lebanon NH, US
Yat Sun Or - Watertown MA, US
Zhe Wang - Hockessin DE, US

Assignee:

Enanta Pharmaceuticals, Inc. - Watertown MA

International Classification:

C07D 401/12
C07D 409/14
A61K 31/38
A61K 31/395
A61P 31/12

US Classification:

51425505, 540455, 540460

Abstract:

The present invention relates to compounds of Formula I or II, or a pharmaceutically acceptable salt, ester, or prodrug, thereof:.

US Patent:

7601709, Oct 13, 2009

Filed:

Feb 6, 2004

Appl. No.:

10/774047

Inventors:

Zhenwei Miao - San Diego CA, US
Ying Sun - Waltham MA, US
Suanne Nakajima - Cambridge MA, US
Datong Tang - Malden MA, US
Frank Wu - Shrewsbury MA, US
Guoyou Xu - Auburndale MA, US
Yat S. Or - Watertown MA, US
Zhe Wang - Hockessin DE, US

Assignee:

Enanta Pharmaceuticals, Inc. - Watertown MA

International Classification:

C07D 245/00
C07D 487/00
A61K 31/33
A01N 43/00

US Classification:

514183, 540471

Abstract:

The present invention relates to compounds of Formula I, II or Ill, or a pharmaceutically acceptable salt, ester, or prodrug, thereof:wherein W is a substituted or unsubstituted heterocyclic ring system. The compounds inhibit serine protease activity, particularly the activity of hepatitis c virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis c virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

US Patent:

7718769, May 18, 2010

Filed:

Nov 20, 2006

Appl. No.:

11/602586

Inventors:

Zhenwei Miao - Medway MA, US
Ying Sun - Waltham MA, US
Suanne Nakajima - Cambridge MA, US
Datong Tang - Malden MA, US
Zhe Wang - Hockessin DE, US
Yat Sun Or - Watertown MA, US

Assignee:

Enanta Pharmaceuticals, Inc. - Watertown MA

International Classification:

A61K 38/00

US Classification:

530333

Abstract:

The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof:.